Diagnosed With Bipolar Disorder And Overweight?

What
The purpose of this placebo controlled research study is to gather information about the effects of investigational medication on weight loss in individuals with stable Bipolar Disorder.

Who
18-65 years old men and women diagnosed with Bipolar Disorder who are obese or overweight and interested in weight loss. Must be on a stable regimen of medication for Bipolar Disorder for at least 3 months.

Pay
Study-related evaluations, tests and medication without charge. Eligible participants will be compensated $50 per visit for their time and travel.

Details
If you would like to fill out a short pre-screen questionnaire for our weight loss in stable bipolar disorder study, please click here.

For more information about the Research Institute, contact (513) 536-0710 or email Anna Guerdjikova at anna.guerdjikova@lindnercenter.org.

Do you suffer from Tardive Dyskinesia?

What
The primary purpose of this clinical research study is to evaluate the safety, tolerability, and persistence of effect of valbenazine after stopping treatment.  If you qualify, you will receive the investigational medication, study-related medical exams, and study-related laboratory services at no cost.  The study lasts approximately 16 weeks.

Who
We invite adults 18 to 85 years old who have been diagnosed with schizophrenia, schizoaffective disorder, or mood disorder, and have medication-induced tardive dyskinesia.

Pay
Eligible participants will be compensated $75 per completed visit (up to $525) for their time and travel.

Details
For more information, contact Brian or George at (513) 536-0707.  To learn more and to see if you (or someone you know) may qualify visit kinected2study.com

Do you want to quit smoking?

Lindner Center of HOPE is conducting a clinical trial of a non‐invasive, investigational medical device, Deep Transcranial Magnetic Stimulation, that may help people to quit smoking.

To be eligible you must:

• Be between the ages of 22– 70 years old
• Have smoked at least 10 cigarettes a day for over a year
• Want to quit smoking

All qualified participants will receive study related exams, lab work and treatments at no cost.
Enrolled participants will receive compensation for time and travel.

For more information, please call Anna at (513) 536-0710 or email anna.guerdjikova@lindnercenter.org.

For more information about the Research Institute, contact (513) 536-0716 or click here.

Diagnosed With Bipolar Disorder And Overweight?

What
The purpose of this placebo controlled research study is to gather information about the effects of investigational medication on weight loss in individuals with stable Bipolar Disorder.

Who
18-65 years old men and women diagnosed with Bipolar Disorder who are obese or overweight and interested in weight loss. Must be on a stable regimen of medication for Bipolar Disorder for at least 3 months.

Pay
Study-related evaluations, tests and medication without charge. Eligible participants will be compensated $50 per visit for their time and travel.

Details
If you would like to fill out a short pre-screen questionnaire for our weight loss in stable bipolar disorder study, please click here.

Non-invasive Spinal Stimulation for the Treatment of Major Depression

What
The purpose of this study is to evaluate whether the use of a small electrical current applied through the skin is useful and safe in the treatment of adults diagnosed with major depression. Participation will last approximately 8 weeks and involve visits to the research center three times per week.

Who
Adults ages 18–55 who are currently moderately depressed for at least 1 month. Not currently on medication treatment for depression.

Pay
Eligible participants will be compensated up to $250 for their time and travel.

Details
For more information, contact Brian or George at 513-536-0707.

If you would like to fill out a short pre-screen questionnaire for our depression study, please click here.

Pediatric Tourette Syndrome (Platinum study)

What:
The primary purpose of this clinical research study is to determine the safety, tolerability, and effectiveness of an investigational medication for Tourette syndrome in children. An investigational medication is one that is not approved by the US Food and Drug Administration (FDA).

Who:
Boys and girls aged 6–17 years.  Have a diagnosis of Tourette syndrome and symptoms that impair school, occupational, and/or social function.  Are in good general health, as determined by medical history, physical examination, and laboratory tests.

Study schedule:

Attend a screening visit to determine your eligibility. Participation in this study will last approximately 11 months (including up to 28 days of screening), 36 weeks of dosing, and a final study visit (done 4 weeks after you take the final dose). The entire study consists of up to 17 study visits, including the screening visit.

For more information, please call (513) 536-0707 or visit https://tforceplatinum.com/or view https://www.youtube.com/watch?v=LgJP5uzDj2I

Do you suffer from Post-Traumatic Stress Disorder (PTSD)?

What
The purpose of this study is to to see if deep repetitive transcranial magnetic stimulation (DTMS) is effective in treating subjects suffering from PTSD. Repetitive transcranial magnetic stimulation is a brain stimulation technique. It involves generating a brief magnetic field in a coil that is placed on the scalp.
DTMS is investigational, which means that this therapy is not approved by the Food and Drug Administration. Participants will receive real or sham (inactive) DTMS 3 times a week for 4 consecutive weeks. There are also 2 follow-up visits.

Who
Adults age 22-68 who have at least moderate PTSD.

Pay
Eligible participants will be compensated $20 per completed visit (up to $320) for their time and travel.

Details
For more information, contact Brian or George at (513) 536-0707 or click here to complete an online pre-screen questionnaire. Located at the Lindner Center of HOPE in Mason, Ohio.

UC 38-18